Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions

August 9, 2019 updated by: Jeffrey L. Schnipper, MD.,MPH., Brigham and Women's Hospital
The objective of this study is to design and implement a set of procedures (the intervention) to improve patients' experiences when they are discharged home from the hospital. Second, this study aims to look at how the intervention affects problems that are known to occur after discharge, including medication issues, worsening medical problems, or readmission to the hospital. The investigators will study how well patients recover the ability to do the things they could before they were admitted to the hospital and their opinions of the discharge process. Lastly, this study will look to understand the best way to implement the intervention into different hospitals and practices, and which types of patients benefit from it most.

Study Overview

Detailed Description

The specific aims of this study are:

  1. To develop, implement, and refine a multi-faceted, multi-disciplinary transitions intervention with contributions from hospital and Patient-Centered Medical Home (PCMH) personnel.

    Hypothesis: a collaborative transitions intervention can be designed and implemented within an ACO that reliably provides the components of an ideal transition in care.

  2. To evaluate the effects of this intervention on post-discharge adverse events, functional status, patient engagement, and emergency department and hospital utilization within 30 days of discharge.

    Hypothesis: compared with usual care, a collaborative transitions intervention will decrease post discharge adverse events, improve post-discharge functional status, increase patient engagement, and reduce emergency department and hospital utilization in the post-discharge period.

  3. To understand barriers to and facilitators of successful implementation of this intervention across practices.

Hypothesis: several barriers to and facilitators of implementation can be identified and used to create lessons learned for other health systems to successfully implement this type of intervention.

Study Type

Interventional

Enrollment (Actual)

1679

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Potential subjects will be adult patients admitted to medical and surgical services at BWH and MGH, likely to be discharged back to the community, and whose PCP belongs to one of the Partners Community Healthcare, Inc. (PCHI) primary care practices that has met "Primed" criteria for being a PCMH, admits at least 2 patients to BWH or MGH, and has agreed to participate. Primed criteria are a standard set of requirements that cover 6 essential building blocks of PCMH practices: electronic health record, patient portal, team-based care, practice redesign, care management, and identification of high-risk patients. We estimate that of the approximately 300 PCHI adult primary care practices, 150 of them will meet PCMH criteria during the study and that 20 of them will qualify and be willing to participate in the study. We estimate that 12,000 such patients will be admitted to BWH and MGH over the 18-month study period, of which we will enroll 1700 patients. These patients are broadly representative of hospitalized patients and include several vulnerable populations, including the elderly (33% 65 or older), patients with multiple chronic conditions (47% with Elixhauser comorbidity score 5 or more), and racial and ethnic minorities (14% African American, 13% Latino).

Exclusion Criteria:

  1. Likely discharge to a location other than home (or to a caregiver's home)
  2. Police custody
  3. No telephone or homeless
  4. Previous enrolment in the study
  5. Patient unable to communicate in either English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Experimental: Multi-Model Intensive Discharge Program
  1. Inpatient medication safety interventions
  2. Inpatient "discharge advocate"
  3. Structured visiting nurse (VNA) appointments
  4. Post-discharge phone call by primary care personnel within 2 business days of discharge
  5. Structured post-discharge clinic appointment with PCP and other PCMH personnel within 2 weeks of discharge
  6. Improved communication between inpatient and primary care teams
  7. High-risk patients will receive additional interventions as needed:

    1. Home pharmacist visit
    2. Enrollment in the Partners integrated Care Management Program (iCMP)
    3. Enrollment in telemedicine programs for patients with CHF
    4. Palliative care consultation regarding goals of care
  8. Novel health information technology to facilitate communication and transfer of clinical information

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Participants With an Adverse Event Within 30 Days After Index Discharge Date
Time Frame: 30 days after discharge
Proportion of Participants With an Adverse Event Within 30 Days after Index Discharge Date
30 days after discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Participants With New or Worsening Signs/Symptoms Within 30 Days of Discharge
Time Frame: 30 days after discharge
New or worsening signs or symptoms, i.e. unpleasant symptoms, loss of function, abnormal lab results, and/or additional medical care within 30 days after discharge.
30 days after discharge
Number of Patients With a Nonelective Readmission Within 30 Days of the Index Discharge Date
Time Frame: 30 days after discharge
Nonelective readmission within 30 days of the index discharge date
30 days after discharge
Change in Functional Status on the Modified Medical Outcomes Survey Short Form-12 (SF-12v2) From One Month Prior to Admission to 30 Days After Discharge.
Time Frame: One month prior to admission to 30 days after discharge.

During the inpatient enrollment period, patients will complete a modified Medical Outcomes Survey Short Form-12 (SF-12v2). The SF-12v2 measures a patient's functional status and health-related quality of life one month prior to admission. 30 days after discharge, SF12 questions will be repeated so that functional status and health-related quality of life can be compared to prior to admission.

This measure is a 12-item measure. Each item 5 possible responses with a value from 1 to 5 (with higher scores indicating worse outcomes). A summary score is computed by summing the score on each item. Therefore, the range of summary scores for the SF-12v2 is a minimum of 12 and a maximum of 60.

One month prior to admission to 30 days after discharge.
Proportion of Participants With Positive Responses Regarding Patient Engagement and Opinions of the Discharge Process
Time Frame: 30 days after discharge

During the 30 day post-discharge follow-up phone call we asked patients about their participation in, understanding of, and ability to carry out the post-discharge plan. These questions include questions from the Interpersonal Processes of Care survey and several additional questions from the HOMERUN study of readmitted patients.

In the table below, we have abbreviated each survey question since the number of characters is limited in this field in the table. We have pasted below the full survey question.

  1. When you were getting ready to leave the hospital one month ago, how often did your care team use medical terminology that you did not understand?
  2. How often did you feel confused about what was going on with your medical care because they did not explain things well?
  3. How often did they give you enough time to say what you thought was important regarding your medical care?
  4. How often did they listen carefully to what you had to say?
  5. How often did you feel p
30 days after discharge
Post-Discharge Health Care Utilization
Time Frame: 30 days after discharge
We will measure emergency department visits and hospital readmissions within 30 days of discharge using a combination of administrative data for all Partners hospitals plus patient report for all utilization outside the Partners system.
30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

November 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

May 1, 2014

First Submitted That Met QC Criteria

May 2, 2014

First Posted (Estimate)

May 5, 2014

Study Record Updates

Last Update Posted (Actual)

August 20, 2019

Last Update Submitted That Met QC Criteria

August 9, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Voluntarily participating in PCORI's Open Science Pilot

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Engagement

Clinical Trials on Multi-Model Intensive Discharge Intervention

3
Subscribe